about
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers.Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea.Increasing LH pulsatility in women with hypothalamic amenorrhoea using intravenous infusion of Kisspeptin-54.Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage.The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans.Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy menEfficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels.Effects of neurokinin B administration on reproductive hormone secretion in healthy men and women.A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.Age-dependent elevations in plasma kisspeptin are observed in boys and girls when compared with adults.A single injection of kisspeptin-54 temporarily increases luteinizing hormone pulsatility in healthy women.The effects of kisspeptin on gonadotropin release in non-human mammals.Follicle Size on Day of Trigger Most Likely to Yield a Mature Oocyte.Frequent falls and confusion: recurrent hypoglycemia in a patient with tuberous sclerosis complex.Hypothalamic Response to Kisspeptin-54 and Pituitary Response to Gonadotropin-Releasing Hormone Are Preserved in Healthy Older Men.Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization TreatmentModulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functionsClinical and biochemical characteristics of patients presenting with pituitary apoplexyThe identification of elevated urinary kisspeptin-immunoreactivity during pregnancyAcute and chronic effects of kisspeptin-54 administration on GH, prolactin and TSH secretion in healthy womenInterpretation of Serum Gonadotropin Levels in HyperprolactinaemiaThe effects of kisspeptin on β-cell function, serum metabolites and appetite in humansAnti-Müllerian hormone (AMH) in the Diagnosis of Menstrual Disturbance Due to Polycystic Ovarian SyndromeEffects of Peptide YY on the Hypothalamic-Pituitary-Gonadal Axis in Healthy MenDeregulation of miR-324/KISS1/kisspeptin in early ectopic pregnancy: mechanistic findings with clinical and diagnostic implicationsClinical Translational Studies of Kisspeptin and Neurokinin BDetermining the Relationship Between Hot Flushes and LH Pulses in Menopausal Women Using Mathematical Modeling
P50
Q33944146-5FD4239A-3341-4247-84DE-E7FC67607031Q33953607-0E50C527-DCCE-48F6-8677-9E50F081B0B6Q34146171-2A730B4B-8F1E-48C7-8EF0-65E454065E62Q34396440-2F7842C6-DDB8-4066-B590-20C7C832F080Q34628390-54E40BD4-3498-4CE2-931E-8EE8468C1BBDQ35597895-AD1A57D4-BB79-4B23-A2DE-3B75C2C3945FQ35865987-3E54FC0A-07CA-4B06-A7D7-F0723EF627EAQ36060453-E89F0657-C2D1-4225-AD72-1954BCDB6562Q37024022-AF226530-B35E-4351-881F-5308EE5FD32CQ37634265-AE53192C-D937-461B-AC69-CC07624932F1Q38371465-78D56B4A-14BF-41B1-8398-1F05C5D081B2Q45150654-106CFD25-91EE-459D-9908-45E78D3700FBQ45164099-C11F441B-F217-466B-B96C-187C929DAD14Q48099895-56564633-FBB6-4999-B1FB-E54C4544AE1EQ55009345-56D43225-3112-43DA-9F99-274429AB721EQ55026079-E855D20D-3A00-4E26-AC12-19BBA84CF406Q55381822-21AB3E4D-7197-4644-AF5A-C68FB671D7B2Q57177405-F456A3D5-6488-4D10-9361-0B523A50FC59Q58599420-26D3B91E-92CE-4BB0-8070-E567EB43D382Q58716648-ADA6F38A-311B-4EE9-9BDC-AD3DEC67D5EAQ61971964-232595B4-92ED-4E79-A4AE-88D9FFA3ADEDQ61971968-23E26360-08F9-4409-AAB2-A6C7B7F5F1E6Q88373519-1FE8D70E-3BB0-4BDE-86AA-7A88AAD4C295Q89426607-08E806B0-6923-4F31-8326-3B2B2E6C3591Q90732825-42BDED21-3C87-4D25-A965-8F94F22C18C8Q90813266-EE3BC41D-34B4-431B-8178-0779BC539FFAQ91305612-47CCA9DF-6E9C-419D-856B-A7FDCBF9A111Q92209693-26847CBA-43A5-4B3E-BDD0-873F491D59FAQ93096521-34812DE4-4349-4E58-B8B7-7EC28D8693DB
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
A Abbara
@ast
A Abbara
@en
A Abbara
@es
A Abbara
@nl
A Abbara
@sl
type
label
A Abbara
@ast
A Abbara
@en
A Abbara
@es
A Abbara
@nl
A Abbara
@sl
prefLabel
A Abbara
@ast
A Abbara
@en
A Abbara
@es
A Abbara
@nl
A Abbara
@sl
P106
P31
P496
0000-0003-2795-5256